title: Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial ACTH deficiency.
abstract: BACKGROUND
  Glucocorticoid therapy is associated with potentially serious side-effects, but there is no information available regarding glucocorticoid requirement in adult hypopituitary patients with partial ACTH deficiency.
  
  
  METHODS
  Ten male adult hypopituitary patients with partial ACTH deficiency, baseline plasma cortisol > 200 nmol/l but a peak stimulated cortisol < 500 nmol/l and 10 matched healthy male control volunteers participated.
  
  
  METHODS
  Patients were assigned, in a random order, to a cross-over protocol of treatment for 1 week with full dose hydrocortisone (10 mg twice daily), half-dose hydrocortisone (5 mg twice daily), or no treatment. All patients completed all three of the treatment limbs.
  
  
  METHODS
  Following each treatment schedule, patients underwent an 11-h cortisol day curve (CDC), and the results were compared with those from the 10 control volunteers on no glucocorticoid treatment.
  
  
  RESULTS
  The integrated CDC values were significantly higher in patients taking a full dose of hydrocortisone compared to controls (P < 0.001). There was no significant difference in the integrated CDC between patients on half-dose (P = 0.37) or no hydrocortisone treatment (P = 0.13), compared to control subjects. Peak postabsorption cortisol values were higher in patients receiving full-dose hydrocortisone treatment compared to controls (P < 0.001). There was no significant difference in plasma sodium concentration, blood pressure or corticosteroid-binding globulin between patients on any treatment schedule and controls.
  
  
  CONCLUSIONS
  Adult patients with pituitary disease and partial ACTH deficiency have a cortisol secretory pattern comparable to that of healthy controls. Conventional full-dose replacement with 10 mg twice daily of hydrocortisone produces hypercortisolaemia, whereas half-dose produces a CDC that is not statistically different from that of healthy controls. The results suggest that current conventional glucocorticoid replacement overtreats patients with partial ACTH deficiency under normal unstressed physiological conditions.
authors.affiliation: Department of Endocrinology, Beaumont Hospital, Dublin, Ireland.
authors.forename: Amar
authors.initials: A
authors.lastname: Agha
authors.forename: Aaron
authors.initials: A
authors.lastname: Liew
authors.forename: Francis
authors.initials: F
authors.lastname: Finucane
authors.forename: Louise
authors.initials: L
authors.lastname: Baker
authors.forename: Patrick
authors.initials: P
authors.lastname: O'Kelly
authors.forename: William
authors.initials: W
authors.lastname: Tormey
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Thompson
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000097:blood / Q000172:deficiency*; D000328:Adult; D000704:Analysis of Variance; D018592:Cross-Over Studies; D004334:Drug Administration Schedule; D005938:Glucocorticoids / Q000097:blood / Q000627:therapeutic use*; D020249:Hormone Replacement Therapy / Q000379:methods*; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D007018:Hypopituitarism / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
chemical_list: D005938:Glucocorticoids; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone